Edition:
United Kingdom

Flex Pharma Inc (FLKS.OQ)

FLKS.OQ on NASDAQ Stock Exchange Global Market

0.43USD
21 Sep 2018
Change (% chg)

$0.01 (+2.02%)
Prev Close
$0.42
Open
$0.41
Day's High
$0.45
Day's Low
$0.40
Volume
134,245
Avg. Vol
66,563
52-wk High
$8.95
52-wk Low
$0.40

Select another date:

Wed, Jun 13 2018

Flex Pharma to scrap two mid-stage neuromuscular disease trials

U.S. drug developer Flex Pharma Inc said on Wednesday it plans to stop two ongoing mid-stage trials, testing its lead drug to treat neuromuscular diseases, following safety concerns.

UPDATE 1-Flex Pharma to scrap two mid-stage neuromuscular disease trials

June 13 U.S. drug developer Flex Pharma Inc said on Wednesday it plans to stop two ongoing mid-stage trials, testing its lead drug to treat neuromuscular diseases, following safety concerns.

Flex Pharma to cut 60 percent of workforce

June 13 U.S. drug developer Flex Pharma Inc said on Wednesday it plans to reduce its workforce by 60 percent, as part of a restructuring, and was ending certain ongoing mid-stage trials.

BRIEF-Flex Pharma Reports Q1 Loss Per Share $0.46

* Q1 EARNINGS PER SHARE VIEW $-0.49 -- THOMSON REUTERS I/B/E/S

BRIEF-Flex Pharma Reports Positive Topline Data From Exploratory Phase 2 Trial Of FLX-787 In Multiple Sclerosis

* FLEX PHARMA REPORTS POSITIVE TOPLINE DATA FROM EXPLORATORY PHASE 2 TRIAL OF FLX-787 IN MULTIPLE SCLEROSIS

Select another date: